PFIZER INC (PFE)
Clinical trial NCT05059522 updates: 1. completion date: 2026-09-30 → 2026-12-31 2. primary completion date: 2026-09-30 → 2026-12-31 3. enrollment: 68 → 77 participants
Clinical trial NCT05059522 updates: 1. completion date: 2026-09-30 → 2026-12-31 2. primary completion date: 2026-09-30 → 2026-12-31 3. enrollment: 68 → 77 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical